C4.4A is a member of the Ly-6 family with restricted expression in non-transformed tissues. C4.4A expression in human cancer has rarely been evaluated. Thus, it became important to explore C4.4A ...

The C2/C3 chassis had an amazing 20-year production run. When Dave McLellan took over as Corvette’s chief engineer in 1975, the Corvette was overdue for a redesign. The only good thing about the 1970s ...

Apparently, C4 Therapeutics' protein degradation tech brings all the Mercks to the yard. The Massachusetts biotech has signed on Merck KGaA in a $740 million biobucks partnership to find two degraders ...

Screens overtaking cars is a controversial trend among enthusiasts, but it wasn’t always. I’ll risk my neck here and say I can’t imagine most people could watch the video below of a 1987 C4 Chevy ...

C4 Therapeutics' zinc finger protein-1 and 3 (IKZF1/3) degrader cemsidomide has demonstrated an overall response rate (ORR) of 50% in a Phase I study in heavily pretreated patients with ...

Unless we're talking about an actual time-traveling DeLorean, there may not be another car that captures 1980s cool, like a C4 Corvette, the fourth-generation version of the car that ran from 1983 to ...

The shelf life of Corvettes has always been problematic; Corvette worshippers who have the latest, greatest plastic fantastic are on top of the world, but the moment word leaks of something newer, the ...